Outcomes of Conventional Cardiac Surgery in Patients with Severely Reduced Ejection Fraction in the Modern Era.
This study evaluates the outcomes of conventional cardiac surgery in patients with a left ventricular ejection fraction (LVEF) ≤25%. Patients with preoperative low LVEF (≤25%) undergoing Society of Thoracic Surgeons (STS) indexed cardiac operations from 2010 to 2018 were included. The primary outcome was survival. Secondary outcomes included major postoperative complications and readmission rates. Multivariable Cox regression was utilized for risk adjustment. Subanalyses evaluated the effect of preoperative inotropes as well as the impact of low LVEF on survival and readmission compared to propensity-matched patients with LVEF>25%. 9,467 patients underwent STS-indexed cardiac operations during the study period including 588 with LVEF ≤25%. The low LVEF group included 397 (67.5%) isolated CABGs, 51 (8.67%) isolated valves, and 140 (23.8%) concomitant CABG valve operations. Survival in low LVEF patients was not impacted by operative procedure but instead by traditional risk factors such as advanced age and medical comorbidities. Freedom from hospital readmission for heart failure was at 57.2% at 5-year follow-up. Patients on preoperative inotropes had reduced survival although the majority were still alive at 5-years (53.1% versus 64.9%, p=0.002). Additionally, propensity-matched LVEF ≤25% and LVEF >25% patients had similar survival and hazards for mortality at 30-days, 1-year and 5-year follow-up. Despite a high-risk profile, patients with reduced preoperative LVEF can undergo conventional cardiac surgery with acceptable outcomes. The majority of patients, including those on preoperative inotropes, were alive and free from heart failure readmissions at 5-years.